dc.contributorUniversidad EAFIT. Departamento de Ingeniería Mecánica
dc.contributorBioingeniería GIB (CES – EAFIT)
dc.creatorFreedland, K.E.
dc.creatorLemos, M.
dc.creatorDoyle, F.
dc.creatorSteinmeyer, B.C.
dc.creatorCsik, I.
dc.creatorCarney, R.M.
dc.date.accessioned2021-04-12T18:59:08Z
dc.date.available2021-04-12T18:59:08Z
dc.date.created2021-04-12T18:59:08Z
dc.date.issued2017-02-01
dc.identifier15732819
dc.identifier1475916
dc.identifierWOS;000394268800009
dc.identifierPUBMED;28239215
dc.identifierSCOPUS;2-s2.0-84982311168
dc.identifierhttp://hdl.handle.net/10784/28159
dc.identifier10.1007/s10608-016-9797-6
dc.description.abstractThe Techniques for Overcoming Depression (TOD) questionnaire assesses the frequency with which patients being treated for depression use cognitive-behavioral techniques in daily life. This study examined its latent structure, reliability and concurrent validity in depressed cardiac patients. The TOD was administered at the initial and final treatment sessions in three trials of cognitive behavior therapy (CBT) (n = 260) for depression in cardiac patients. Mokken scaling was used to determine its dimensionality. The TOD is unidimensional in depressed cardiac patients, both at the initial evaluation (H = .46) and the end of treatment (H = .47). It is sensitive to change and the total score correlates with therapist ratings of the patient’s socialization to CBT (r = .40, p < .05), homework adherence (r = .36, p < .05), and use of cognitive-behavioral techniques (r = .51, p < .01). TOD scores were associated with post-treatment depression scores in two of the trials (p < .01 in both analyses). The TOD is a unidimensional, reliable, valid, and clinically informative measure of self-reported use of cognitive-behavioral techniques for overcoming depression in cardiac patients. Studies of the TOD in other depressed patient populations are needed. © 2016, Springer Science+Business Media New York.
dc.languageeng
dc.publisherSPRINGER/PLENUM PUBLISHERS
dc.relationhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84982311168&doi=10.1007%2fs10608-016-9797-6&partnerID=40&md5=acca8ef8627069237f708c0a37c46f34
dc.relationDOI;10.1007/s10608-016-9797-6
dc.relationWOS;000394268800009
dc.relationPUBMED;28239215
dc.relationSCOPUS;2-s2.0-84982311168
dc.rightshttps://v2.sherpa.ac.uk/id/publication/issn/1573-2819
dc.sourceCognitive Therapy And Research
dc.subjectantidepressant agent
dc.subjectadult
dc.subjectArticle
dc.subjectcardiac patient
dc.subjectcognitive behavioral therapy
dc.subjectconcurrent validity
dc.subjectcoronary artery bypass graft
dc.subjectCronbach alpha coefficient
dc.subjectdepression assessment
dc.subjectfemale
dc.subjectheart failure
dc.subjecthuman
dc.subjectischemic heart disease
dc.subjectmajor clinical study
dc.subjectmajor depression
dc.subjectmale
dc.subjectmiddle aged
dc.subjectMokken scale
dc.subjectpatient compliance
dc.subjectrating scale
dc.subjectself report
dc.subjectsocialization
dc.subjectTechniques for Overcoming Depression questionnaire
dc.subjecttreatment resistant depression
dc.titleThe Techniques for Overcoming Depression Questionnaire: Mokken Scale Analysis, Reliability, and Concurrent Validity in Depressed Cardiac Patients
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typeinfo:eu-repo/semantics/article
dc.typearticle
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typepublishedVersion


Este ítem pertenece a la siguiente institución